Literature DB >> 6221795

In vivo analysis of the suppressive effects of immunosuppressive acidic protein, a type of alpha 1-acid glycoprotein, in connection with its high level in tumor-bearing mice.

Y Shibata, K Tamura, N Ishida.   

Abstract

Suppressed concanavalin A response of spleen cells which appeared on Day 21 in C3H/He mice bearing methylcholanthrene-induced fibrosarcoma was attributed to macrophages. These macrophages were not only immunoglobulin and Thy 1.2 negative and mitomycin C resistant but were also found in the light-specific-gravity (1.077) fraction and were completely removed by carbonyl iron treatment. These suppressor macrophages, however, disappeared 4 days after surgical resection of the tumor, suggesting that the control mechanism originally resides in tumor tissues. Immunosuppressive acidic protein (IAP) levels in the sera of these tumor-bearing mice increased along with the appearance of these suppressor macrophages. Inasmuch as the suppressor macrophages obtained from the spleens of tumor bearers and cultured in vitro produced 4 times more IAP (88 ng/ml) than did resident macrophages, the elevated levels of IAP in the sera of tumor-bearing mice at the late stage might be explained partly by the appearance of suppressor macrophages. On the other hand, an i.v. administration of IAP (5 mg/mouse) into normal mice not only induced the same unresponsiveness of spleen cells to concanavalin A shown by tumor-bearing mice but also induced suppressor macrophages in the spleens of these mice. This fact may indicate that IAP elevation, even though artificial, triggers the induction of suppressor macrophages in the spleen or at least points to a keen correlation between the appearance of suppressor macrophages and increased IAP level in the serum.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6221795

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  17 in total

1.  Relationship between general or specific immunoreactivity and prognosis in postoperative patients with hepatocellular carcinoma.

Authors:  H Yamasaki; E Okamoto; T Komatsu; Y Manabe; S Shinka
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

2.  Orosomucoid 1 drives opportunistic infections through the polarization of monocytes to the M2b phenotype.

Authors:  Kiwamu Nakamura; Ichiaki Ito; Makiko Kobayashi; David N Herndon; Fujio Suzuki
Journal:  Cytokine       Date:  2015-02-14       Impact factor: 3.861

3.  Effect of alpha 1-acidic glycoprotein in the ascitic fluid of cancer patients on human NK cells: selective suppression of interferon-induced NK activation.

Authors:  H Aso; K Tamura; M T Rose; Y Tomioka; M Mizugaki; N Ishida
Journal:  Inflammation       Date:  1999-04       Impact factor: 4.092

4.  Impact of splenectomy and immunochemotherapy on survival following gastrectomy for carcinoma: covariate interaction with immunosuppressive acidic protein, a serum marker for the host immune system. Tumor Marker Committee for the Study Group of Immunochemotherapy with PSK for Gastric Cancer.

Authors:  S Saji; J Sakamoto; S Teramukai; K Kunieda; Y Sugiyama; Y Ohashi; H Nakazato
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

5.  Investigation of serum concentrations and immunohistochemical localization of α1-acid glycoprotein in tumor dogs.

Authors:  Masashi Yuki; Noboru Machida; Takayuki Sawano; Hiroshi Itoh
Journal:  Vet Res Commun       Date:  2010-10-21       Impact factor: 2.459

6.  Immunosuppressive acidic protein in patients with brain tumours: a preliminary report.

Authors:  K Kikuchi; H Gotoh; M Kowada
Journal:  Acta Neurochir (Wien)       Date:  1987       Impact factor: 2.216

7.  Preoperative serum immunosuppressive acidic protein (IAP) test for the prognosis of gastric cancer: a statistical study of the threshold level and evaluation of the effect of the biological response modifier PSK.

Authors:  J Sakamoto; A Koike; S Saji; S Teramukai; Y Ohashi; H Nakazato
Journal:  Surg Today       Date:  1992       Impact factor: 2.549

8.  Modulation of the immunosuppressive effects of splenic macrophages in Fischer rats bearing adenocarcinoma 13762.

Authors:  J Bonaventure; V N Nigam; C A Brailovsky
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

9.  Neutrophil elastase inhibitor (sivelestat) preserves antitumor immunity and reduces the inflammatory mediators associated with major surgery.

Authors:  Shintaro Akamoto; Keiichi Okano; Takanori Sano; Shinichi Yachida; Kunihiko Izuishi; Hisashi Usuki; Hisao Wakabayashi; Yasuyuki Suzuki
Journal:  Surg Today       Date:  2007-04-30       Impact factor: 2.549

10.  The Polarization of M2b Monocytes in Cultures of Burn Patient Peripheral CD14+ Cells Treated with a Selected Human CCL1 Antisense Oligodeoxynucleotide.

Authors:  Ichiaki Ito; Kamlesh K Bhopale; Tomoki Nishiguchi; Jong O Lee; David N Herndon; Sumihiro Suzuki; Lawrence C Sowers; Fujio Suzuki; Makiko Kobayashi
Journal:  Nucleic Acid Ther       Date:  2016-08-22       Impact factor: 5.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.